Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPI-2: Genotype-directed vs Standard Anti-platelet Therapy
NCT01452152Phase 4Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Feb 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prasugrel and clopidogrel in cardiovascular disease (CVD) and acute coronary syndrome (ACS), sponsored by University of Maryland, Baltimore. Started Feb 2012; status: terminated.
02
Drugs
prasugrelclopidogrel
03
Conditions
cardiovascular disease (CVD)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01452152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01452152.